![In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapy]()
In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapyRicco, G.; Cavallone, D.; Pontisso, P.; Fassina, G.; Gallotta, A.; Colombatto, P.; Oliveri, F.; Romagnoli, V.; Coco, B.; Salvati, A.; Bonino, F.; Brunetto, M.R. · Journal of Hepatology · 2017